VistaGen Therapeutics, Inc.
We are a clinical-stage biopharmaceutical company committed to developing new generation therapies for anxiety, depression and certain additional central nervous system (CNS) disorders for which we believe current treatment options are inadequate, resulting in high unmet need in large and growing markets worldwide.
Last Closing Price
August 3, 2020
MAXIM GROUP LLC
This offering is no longer available
Sign Up to participate in future offerings
To view the prospectus for VistaGen Therapeutics, Inc., or any offering listed on ClickIPO,
download the ClickIPO app...
or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277